39943-41-4 Usage
Description
(1-((dimethylamino)methyl)cyclopropyl)methanol is an organic compound with the formula C8H15NO. It features a cyclic, three-membered ring with a hydroxymethyl group and a dimethylamino group. (1-((dimethylamino)methyl)cyclopropyl)methanol is known for its unique structure and properties, making it a promising candidate for various applications in organic synthesis and pharmaceutical research.
Uses
Used in Organic Synthesis:
(1-((dimethylamino)methyl)cyclopropyl)methanol is used as a building block in organic synthesis for the creation of more complex molecules. Its unique structure allows for versatile chemical reactions, making it a valuable component in the synthesis of various organic compounds.
Used in Pharmaceutical Research:
In the pharmaceutical industry, (1-((dimethylamino)methyl)cyclopropyl)methanol is used as a starting material for the development of new drugs. Its biological activity and potential as a drug candidate make it an interesting molecule for further study and development, with the aim of discovering new therapeutic agents.
Used in Drug Development:
(1-((dimethylamino)methyl)cyclopropyl)methanol is employed as a potential drug candidate for various applications. Its biological activity and unique structure make it a promising molecule for the development of new pharmaceuticals, with the potential to address unmet medical needs and improve patient outcomes.
Check Digit Verification of cas no
The CAS Registry Mumber 39943-41-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,9,9,4 and 3 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 39943-41:
(7*3)+(6*9)+(5*9)+(4*4)+(3*3)+(2*4)+(1*1)=154
154 % 10 = 4
So 39943-41-4 is a valid CAS Registry Number.
39943-41-4Relevant articles and documents
Cycloalkyl and heterocycloalkyl inhibitors as well as preparation method and application thereof
-
Paragraph 0317-0321, (2021/04/26)
The invention relates to cycloalkyl and heterocycloalkyl inhibitors as well as a preparation method and application thereof. Specifically, the compounds disclosed by the invention have a structure as shown in a formula (I). The invention also discloses a preparation method of the compounds and application of the compounds as KRASG12C inhibitors. The compounds have a good selective inhibition effect on KRASG12C, and have better pharmacodynamic and pharmacokinetic properties and lower toxic and side effects.
